Pricing Log in Create free account

Dianthus Therapeutics, Inc. (DNTH) vs Tango Therapeutics, Inc. (TNGX)

Dianthus Therapeutics, Inc. and Tango Therapeutics, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. and Tango Therapeutics, Inc. are of similar size ($4.2B and $3.8B). Tango Therapeutics, Inc. grew revenue faster over the last twelve months: 48.3% against −60.8%. Tango Therapeutics, Inc. has the higher net margin (0.00% vs −10,097.0%) and the lower return on invested capital (−808.4% vs −47.7%). Across the 15 metrics below, Tango Therapeutics, Inc. leads on 12 and Dianthus Therapeutics, Inc. on 3.

Valuation

Metric DNTH TNGX Biotechnology median
P/E n/m n/m 8.50
P/S 2,121.40 52.95 9.71
P/B 3.45 3.22 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1,655.63 36.70 9.21
Earnings yield (5.76%) (3.81%) (33.15%)
Free cash flow yield (3.86%) (4.37%) (25.50%)

Profitability

Metric DNTH TNGX Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (11,441.39%) 0.00% 0.00%
Net margin (10,096.95%) 0.00% 0.00%
Free cash flow margin (8,177.99%) 0.00% 0.00%
Return on equity (26.07%) (21.34%) (56.36%)
Return on assets (24.98%) (18.86%) (48.04%)
Return on invested capital (47.74%) (808.35%) 0.00%

Growth

Metric DNTH TNGX Biotechnology median
Revenue growth (TTM) (60.77%) 48.29% 6.02%
EPS growth (last fiscal year) (64.71%) 26.89% 30.26%
Revenue growth, 5-year CAGR — 52.13% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNTH TNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 26.10 50.82 4.72
Net debt to EBITDA 2.20 3.08 0.96

Dividend

Metric DNTH TNGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DNTH TNGX Biotechnology median
Market cap 4.17b 3.83b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack